Vibozilimod

CAS No. 1403232-33-6

Vibozilimod( —— )

Catalog No. M35071 CAS No. 1403232-33-6

Vibozilimod (SCD-044) is S1P receptor-1 (S1PR1) agonist .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 103 Get Quote
5MG 164 Get Quote
10MG 226 Get Quote
25MG 380 Get Quote
50MG 548 Get Quote
100MG 734 Get Quote
200MG 972 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vibozilimod
  • Note
    Research use only, not for human use.
  • Brief Description
    Vibozilimod (SCD-044) is S1P receptor-1 (S1PR1) agonist .
  • Description
    Vibozilimod (SCD-044, example 33) is a S1p1 receptor agonist (extracted from patent WO2012140020A1).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    S1P Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1403232-33-6
  • Formula Weight
    542.07
  • Molecular Formula
    C29H36ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?Ethanol : 1.92 mg/mL (3.54 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60°C)
  • SMILES
    COCCOCC1(CCN(Cc2ccc(cc2)-c2noc(n2)-c2ccc(CC(C)C)c(Cl)c2)CC1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Marc Capet, et al. Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists. Patent. WO2012140020A1.
molnova catalog
related products
  • Complanatoside A

    Complanatoside A is a flavonol glycoside isolated from Astragalus complanatus.

  • SAR-114137

    SAR-114137 is a histone sphingomyelin kinase inhibitor used in the study of molluscum arteriosum and peripheral neuropathic pain.

  • Ex26

    Ex26 (S1P1-IN-Ex26) is a selective and potent sphingosine 1-phosphate receptor 1 (S1P1) antagonist that disrupts SR-B1-S1PR1 interactions and inhibits S1P-S1PR1 signaling.